The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Agreed - I bought when they were in the 60's due to good reports - about to have a further dabble whilst the price is still relatively low because I can see this one starting to climb
They seem to be gathering momentum and that's what they badly needed. There cost base is in place and if they keep that under control the margins should be huge.
Only have 10K which I bought in the 40's. Will top-up if dips below 50p for no good reason :)
Good news - although $1m over three years isn't earth shattering, but positive....
11 December 2019
Pelatro Plc
("Pelatro" or the "Group")
Pelatro chosen to provide Business Consultancy for Campaign Management
Pelatro Plc (AIM: PTRO), the global Multichannel Marketing Hub software specialist, is pleased to announce another contract win that further establishes its position in the industry as a company with significant domain expertise to assist telcos in their campaign management activities.
The Group has been selected by one of its existing customers in Asia to provide Business Consultancy for the campaign management activities of the telco. The telco became a customer of Pelatro in 2018 by procuring the licence for mViva Contextual Marketing Solution for campaign management activities. The product went live in their network in early 2019 and the telco has been sending campaigns since then.
This has demonstrated to the telco that relying on the domain expertise of Pelatro to analyse data, devise the campaigning strategy and design appropriate campaigns will enable them to further increase their revenue and reduce churn. As a result, the telco has entered into an agreement with Pelatro for this scope of work as a monthly fixed fee cum gain share engagement. The revenue potential to Pelatro is about US$ 1 million over three years. The agreement is in line with and further validation of the Group's strategy of pursuing deals which brings better quality and higher visibility to our future revenues.
Commenting on this contract win, Subash Menon, Managing Director said: "We are delighted to be chosen for this project with our existing customer as it is further acknowledgement of our domain expertise, ability to cross sell value added services. Further, this will open up a new annuity revenue stream for Pelatro from existing licence customers in line with our strategy of pursing agreements with higher visibility and recurring revenue."